Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

TScan Therapeutics (TCRX) Return on Assets (2021 - 2025)

TScan Therapeutics (TCRX) has disclosed Return on Assets for 5 consecutive years, with 0.53% as the latest value for Q4 2025.

  • Quarterly Return on Assets fell 18.0% to 0.53% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.53% through Dec 2025, down 18.0% year-over-year, with the annual reading at 0.43% for FY2025, 4.0% down from the prior year.
  • Return on Assets for Q4 2025 was 0.53% at TScan Therapeutics, down from 0.5% in the prior quarter.
  • The five-year high for Return on Assets was 0.25% in Q4 2021, with the low at 0.53% in Q4 2025.
  • Average Return on Assets over 5 years is 0.36%, with a median of 0.36% recorded in 2022.
  • The sharpest move saw Return on Assets rose 10bps in 2023, then fell -20bps in 2025.
  • Over 5 years, Return on Assets stood at 0.25% in 2021, then plummeted by -47bps to 0.36% in 2022, then grew by 13bps to 0.32% in 2023, then dropped by -11bps to 0.35% in 2024, then tumbled by -50bps to 0.53% in 2025.
  • According to Business Quant data, Return on Assets over the past three periods came in at 0.53%, 0.5%, and 0.43% for Q4 2025, Q3 2025, and Q2 2025 respectively.